Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2829717rdf:typepubmed:Citationlld:pubmed
pubmed-article:2829717lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0949782lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0028902lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0332325lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0376211lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0680242lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2829717lifeskim:mentionsumls-concept:C0073764lld:lifeskim
pubmed-article:2829717pubmed:issue11lld:pubmed
pubmed-article:2829717pubmed:dateCreated1988-3-11lld:pubmed
pubmed-article:2829717pubmed:abstractTextThe mechanism of action of the quinolone analogs ofloxacin and S-25930, which are unusual because of the presence of a third ring with an asymmetric carbon, was studied. Drug-resistant strains of Escherichia coli were selected by serial passage in the presence of ofloxacin, and a mutation was mapped near the gyrA gene of DNA gyrase. DNA gyrase containing the A subunit purified from this strain as compared with the isogenic wild-type strain exhibited increased resistance to ofloxacin, proving that the mutation was located in the gyrA gene. For S-25930, the S stereoisomer was more potent than the R isomer in inhibiting wild-type E. coli and DNA gyrase containing an A subunit isolated from this strain. Both isomers had decreased potency against the isogenic ofloxacin-resistant (gyrA) strain and its purified enzyme, but the S isomer remained more potent than the R isomer. These studies, using a combined genetic and biochemical approach, demonstrate (i) that DNA gyrase is a target of the tricyclics ofloxacin and S-25930, (ii) that serial exposure to ofloxacin can select resistance to tricyclic quinolone agents by mutation in the gyrA gene, and (iii) that the more potent antibacterial activity of S relative to R S-25930 correlates with increased activity against DNA gyrase for both wild-type and ofloxacin-resistant (gyrA) isogenic strains.lld:pubmed
pubmed-article:2829717pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:languageenglld:pubmed
pubmed-article:2829717pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:citationSubsetIMlld:pubmed
pubmed-article:2829717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2829717pubmed:statusMEDLINElld:pubmed
pubmed-article:2829717pubmed:monthNovlld:pubmed
pubmed-article:2829717pubmed:issn0066-4804lld:pubmed
pubmed-article:2829717pubmed:authorpubmed-author:SwartzM NMNlld:pubmed
pubmed-article:2829717pubmed:authorpubmed-author:McHughG LGLlld:pubmed
pubmed-article:2829717pubmed:authorpubmed-author:HooperD CDClld:pubmed
pubmed-article:2829717pubmed:authorpubmed-author:WolfsonJ SJSlld:pubmed
pubmed-article:2829717pubmed:authorpubmed-author:SG MGMlld:pubmed
pubmed-article:2829717pubmed:authorpubmed-author:SouzaK SKSlld:pubmed
pubmed-article:2829717pubmed:issnTypePrintlld:pubmed
pubmed-article:2829717pubmed:volume31lld:pubmed
pubmed-article:2829717pubmed:ownerNLMlld:pubmed
pubmed-article:2829717pubmed:authorsCompleteYlld:pubmed
pubmed-article:2829717pubmed:pagination1861-3lld:pubmed
pubmed-article:2829717pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:meshHeadingpubmed-meshheading:2829717-...lld:pubmed
pubmed-article:2829717pubmed:year1987lld:pubmed
pubmed-article:2829717pubmed:articleTitleAntagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.lld:pubmed
pubmed-article:2829717pubmed:affiliationMedical Services, Massachusetts General Hospital, Boston 02114.lld:pubmed
pubmed-article:2829717pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2829717pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2829717pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2829717lld:pubmed